EUVIMEDEUVIMED entdecken
Crossref

Pediatric systemic juvenile idiopathic arthritis‐related lung disease: Description of clinical cohort and review of management

Chandra Swanson, Erin K Khan, Ashley Cooper, Maria Ibarra, Jade Tam-Williams iD

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.26821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Chandra Swanson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Sleep Medicine, Children's Mercy - Kansas City, Kansas City, Missouri, USA. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Lung Diseases, Interstitial, Macrophage Activation Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Since the early 2010s, there has been an increased awareness of interstitial lung disease in systemic juvenile idiopathic arthritis (sJIA‐LD) in pediatric patients. Despite the increase in prevalence of sJIA‐LD, little is known about this disease process and effective therapeutic management.

Objectives

To identify and characterize the disease process and management of interstitial lung disease related to systemic juvenile idiopathic arthritis. Study Design In this single‐center, retrospective case series of 9 patients, we analyze demographic, clinical, radiographic, and laboratory data to corroborate common clinical characteristics and describe an approach for diagnosis and monitoring of sJIA‐LD. Data Extraction All data was extracted through electronic medical records and individually reviewed by two pediatric pulmonologists and two pediatric rheumatologists.

Results

Our results were similar to other described cases of sJIA‐LD as patients in our cohort were more likely to be younger, have a history of macrophage activation syndrome and prior use of biologic therapies. In contrast to prior studies, they did not present with peripheral lymphadenopathy and hepatosplenomegaly.

Limitations

The cohort size was small and data is reflective of one center's approach to management of a rare lung disease process.

Conclusion

Interstitial lung disease due to sJIA is rare and management can be difficult in these complex patients.More research is necessary to understand the increased incidence and treatment of sJIA‐LD in pediatric population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, JuvenileLung Diseases, InterstitialMacrophage Activation SyndromeChildHumansRetrospective StudiesLung

Stichwörter der Autor:innen

childhood interstitial lung diseaseinterstitial lung diseasepediatricsystemic juvenile idiopathic arthritis

Autor:innen und Institutionen

  • Department of Pulmonary and Sleep Medicine, Children's Mercy - Kansas City, Kansas City, Missouri, USA.

ORCID-Profile: Jade Tam-Williams

Zitieren

APA

Swanson, C., Khan, E. K., Cooper, A., Ibarra, M., & Tam-Williams, J. (2024). Pediatric systemic juvenile idiopathic arthritis‐related lung disease: Description of clinical cohort and review of management. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26821

Vancouver

Swanson C, Khan EK, Cooper A, Ibarra M, Tam-Williams J. Pediatric systemic juvenile idiopathic arthritis‐related lung disease: Description of clinical cohort and review of management. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26821

BibTeX
@article{Swanson2024,
  author = {Swanson, Chandra and Khan, Erin K and Cooper, Ashley and Ibarra, Maria and Tam-Williams, Jade},
  title = {Pediatric systemic juvenile idiopathic arthritis‐related lung disease: Description of clinical cohort and review of management},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.26821}
}
Kostenlos starten →